Ligand Pharma

$89.30 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Ligand Pharma

Ligand Pharmaceuticals Incorporated (Ligand) is a biopharmaceutical company. The Company is focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. The Company's technology includes Captisol Technology, OmniAb Technologies (OMT), Icagen Ion Channel Technology Platform, Pelican Expression Technology platform and Liver Targeting Prodrug (LTP) Technology to assist companies in their work toward securing prescription drug and biologic approvals. It has partnerships and license agreements with over 130 pharmaceutical and biotechnology companies and over 300 programs that are in various stages of commercialization, development or research and are fully funded by its collaboration partners and licensees. Its partners and licensees have programs in clinical development targeting seizure, coma, cancer, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Stock Analysis

last close $89.3
1-mo return 9.5%
3-mo return -22.5%
avg daily vol. 176.34T
52-week high 169.98
52-week low 72.57
market cap. $1.3B
forward pe 38
annual div. -
roe 3.1%
ltg forecast 15%
dividend yield -
annual rev. $268M
inst own. 95.1%

Subscribe now for daily local and international financial news